J&J’s Vaccine Trial Enters Phase 3; Tesla & Nikola: What’s Next for Electric Vehicles

To listen to this podcast episode, click on the Play button in the bar at the bottom of the screen. To listen while browsing, click on the Expand button at the bottom right to launch the player in a new browser tab/window.

Johnson & Johnson is the latest drugmaker to enter a late-stage trial for a coronavirus vaccine. The company’s Chief Scientific Officer, Dr. Paul Stoffels, shares the process and next steps for a safe, widely effective vaccine. CNBC’s Phil LeBeau recaps the highly anticipated Tesla Battery Day with reactions from Wall Street and Main Street. Tesla competitor Nikola has also captured headlines after founder and chairman Trevor Milton announced he’s leaving the company just 13 days after he and General Motors CEO Mary Barra announced a partnership. Former Ford CEO Mark Fields discusses what’s next for the transaction and for GM’s shareholders. Plus, Ronald Perelman is a legendary financier and billionaire, but he’s begun liquidating hundreds of millions of dollars in assets. CNBC’s Robert Frank reveals what he’s selling and explores why he might need the cash. 

Learn more about your ad choices. Visit

Leave a Reply

The Day We Got Lazy

China pledges to be carbon neutral by 2060. Johnson & Johnson begins final stage of its one-dose Covid19 vaccine trial. Elon Musk unveils new battery technology that will drive down costs.